SCHEMBL6064587

SCHEMBL6064587

C=C(c1ccc(O)c(O)c1)c1ccc2cccc(O)c2n1.C=C(c1ccc(O)c(O)c1)c1ccc2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B14 Q9BPX1 2/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ PIM1 P11309 1/20 0.43
▸ CNR2 P34972 5/20 0.38
▸ MGAM O43451 1/20 0.38
▸ METAP2 P50579 1/20 0.38
▸ PLAU P00749 1/20 0.38
▸ NCF1 P14598 1/20 0.38
▸ ALOX12 P18054 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3836704 0.92 KMT2A (0.51) HSD17B14KMT2AKDM4EPIM1METAP2
SCHEMBL3860500 0.91 HSD17B14 (0.52) HSD17B14KDM4ECNR2MGAMALDH1A1
SCHEMBL3825336 0.79 KDM4E (0.53) HSD17B14KMT2AKDM4EPIM1METAP2
SCHEMBL8746411 0.72 CNR2 (0.47) HSD17B14KMT2AKDM4ECNR2MGAM
SCHEMBL28605670 0.72 CNR2 (0.62) KMT2AKDM4ECNR2MGAMALDH1A1
SCHEMBL9335143 0.72 CNR2 (0.48) HSD17B14KMT2AKDM4ECNR2MGAM
SCHEMBL7245263 0.72 PTPN1 (0.44) HSD17B14KMT2AKDM4EALDH1A1HPGD
SCHEMBL28443611 0.72 MGAM (0.61) KMT2AKDM4ECNR2MGAMNCF1
SCHEMBL8617775 0.71 MGAM (0.49) HSD17B14KMT2AKDM4ECNR2MGAM
SCHEMBL7243815 0.70 PIM1 (0.57) KDM4EPIM1ALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006129134-A1 SYNERGIC COMBINATIONS COMPRISING A STYRYLQUINOLINE COMPOUND AND OTHER HIV INFECTION THERAPEUTIC AGENTS BIOALLIANCE PHARMA (FR) 2006-12-07 — — WO claimed
Send feedback